Human CD85a/LILRB3 Antibody (7C5) is a research-grade biosimilar monoclonal antibody targeting CD85. It is a human IgG1 antibody. Reactivity: Human. Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% purity as determined by SDS-PAGE. For research use only.
Leukocyte immunoglobulin-like receptor subfamily B member 3 (CD85a/LILRB3) is a ~69 kDa protein. May act as receptor for class I MHC antigens. Becomes activated upon coligation of LILRB3 and immune receptors, such as FCGR2B and the B-cell receptor. Down-regulates antigen-induced B-cell activation by recruiting phosphatases to its immunoreceptor tyrosine-based inhibitor motifs (ITIM).
Product Name:
Human CD85a/LILRB3 Antibody (7C5)
SKU:
GXBS02154
Size:
100 µg, 1 mg
Antibody Type:
Monoclonal Antibody
Clone:
7C5
Target:
CD85a
Isotype:
IgG1
Host Species:
Human
Reactivity:
Human
Applications:
ELISA, FCM, Functional assay, Research in vivo
Expression Host:
Mammalian cells
Synonyms:
CD85a, ILT-5, Monocyte inhibitory receptor HL9, LILRB3, Immunoglobulin-like transcript 5, CD85 antigen-like family member A, ILT5, Leukocyte immunoglobulin-like receptor 3, LIR-3, Leukocyte immunoglobulin-like receptor subfamily B member 3, LIR3
Purity:
>95% as determined by SDS-PAGE.
Endotoxin Level:
< 10 EU/mg
Formulation:
0.01M PBS pH 7.4.
State of Matter:
Liquid
Regulatory Status:
For research use only. Not suitable for clinical or therapeutic use.
Product Preparation:
Protein A/G purified from cell culture supernatant.
Storage and Handling:
Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
